FDA Commissioner Hamburg Anticipates "Intense Engagement" With Congress
This article was originally published in The Pink Sheet Daily
Executive Summary
"This is a moment when we need to really boost our message and demonstrate, in a very proactive way, what we do, how we do it and why it's important," she tells agency's Science Board.
You may also be interested in...
Elections Reshape FDA Oversight Scene On Capitol Hill
Potential FDA appropriations chairman was an early advocate of drug importation.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: